Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin for Cognitive Function in TBI Patients with GH Deficiency
NCT00432263Phase 4Withdrawn
- Sponsor
- Pfizer
- Start
- Apr 2007
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of genotropin miniquick in growth hormone deficiency (GHD), sponsored by Pfizer. Planned start Apr 2007; status: withdrawn.
02
Drugs
genotropin miniquick
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00432263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432263.